BioWorld - Tuesday, March 31, 2026

BioWorld Science

Feb. 23, 2022

View Archived Issues

Blockade of HIF-1 leads to ROS overproduction in diabetes

Read More

MZE-001 shows promising results in murine and canine models of Pompe disease

Read More

S-05014, a novel tyrosinase inhibitor with promising anti-Parkinsonian activity

Read More

Discovery of novel peptides as probes for crotamine

Read More

Ideaya Biosciences presents POLQ inhibitors

Read More

U.S. researchers divulge CDK19 inhibitors

Read More

Columbia University discloses CD33/CD45 interaction inhibitors

Read More

New IRAK and FLT3 inhibitors described by U.S. investigators

Read More

Mirati Therapeutics synthesizes new SOS1 inhibitors

Read More

New DNA Damage Response Consortium seeks to advance brain cancer research

Read More

Microlyse targets VWF and clears microvascular thrombosis

Read More

Code Bio and Takeda collaborate on gene therapies for rare diseases

Read More

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Read More

Phio's INTASYL-based antiviral compounds against SARS-CoV-2 enter in vivo testing

Read More

Actinium and AVEO collaborate to develop novel Ac-225 ErbB3-targeted radiotherapy

Read More

ALPHA-1062 shown to be neuroprotective in rodent model of traumatic brain injury

Read More

JBC-1847 proven effective against Staphylococcus aureus infection

Read More

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Read More

Sorrento's STI-9167 shows neutralizing activity against SARS-CoV-2 Omicron variants

Read More

Novel target identified for long QT

Read More